| Heterogeneity of tumour‐infiltrating lymphocytes in breast cancer and its prognostic significance M Althobiti, MA Aleskandarany, C Joseph, M Toss, N Mongan, ... Histopathology 73 (6), 887-896, 2018 | 77 | 2018 |
| Breast cancer intratumour heterogeneity: current status and clinical implications C Joseph, A Papadaki, M Althobiti, M Alsaleem, MA Aleskandarany, ... Histopathology 73 (5), 717-731, 2018 | 68 | 2018 |
| Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer C Joseph, M Arshad, S Kurozomi, M Althobiti, IM Miligy, S Al-Izzi, MS Toss, ... Breast Cancer Research and Treatment 174, 387-399, 2019 | 55 | 2019 |
| Enhanced glutamine uptake influences composition of immune cell infiltrates in breast cancer RE Ansari, ML Craze, M Althobiti, L Alfarsi, IO Ellis, EA Rakha, AR Green British journal of cancer 122 (1), 94-101, 2020 | 37 | 2020 |
| The role of PIP5K1α/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1α inhibitor M Sarwar, AS Syed Khaja, M Aleskandarany, R Karlsson, M Althobiti, ... Oncogene 38 (3), 375-389, 2019 | 31 | 2019 |
| The prognostic significance of ALDH1A1 expression in early invasive breast cancer M Althobiti, R El Ansari, M Aleskandarany, C Joseph, MS Toss, AR Green, ... Histopathology 77 (3), 437-448, 2020 | 27 | 2020 |
| The prognostic significance of BMI1 expression in invasive breast cancer is dependent on its molecular subtypes M Althobiti, AA Muftah, MA Aleskandarany, C Joseph, MS Toss, A Green, ... Breast cancer research and treatment 182, 581-589, 2020 | 16 | 2020 |
| The ITIM-containing receptor: leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) modulates immune response and confers poor prognosis in invasive breast carcinoma C Joseph, MA Alsaleem, MS Toss, YA Kariri, M Althobiti, S Alsaeed, ... Cancers 13 (1), 80, 2020 | 14 | 2020 |
| Nucleolar protein 10 (NOP10) predicts poor prognosis in invasive breast cancer KA Elsharawy, M Althobiti, OJ Mohammed, AI Aljohani, MS Toss, ... Breast cancer research and treatment 185, 615-627, 2021 | 10 | 2021 |
| Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer M Althobiti, KA El-Sharawy, C Joseph, M Aleskandarany, MS Toss, ... Breast Cancer Research and Treatment 189 (3), 621-630, 2021 | 5 | 2021 |
| The clinical and biological significance of estrogen receptor-low positive breast cancer S Makhlouf, M Althobiti, M Toss, AA Muftah, NP Mongan, AHS Lee, ... Modern Pathology 36 (10), 100284, 2023 | 2 | 2023 |
| Deciphering invasive breast cancer heterogeneity for personalised therapy M Althobiti University of Nottingham, 2021 | | 2021 |
| Enhanced glutamine uptake influences composition of immune cell infiltrates in breast cancer R El Ansari, ML Craze, M Althobiti, L Alfarsi, IO Ellis, EA Rakha, AR Green BRITISH JOURNAL OF CANCER 122 (1), 94-101, 2020 | | 2020 |
| The ITIM-Containing Receptor: Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) Modulates Immune Response and Confers Poor Prognosis in Invasive Breast Carcinoma … C Joseph, MA Alsaleem, MS Toss, YA Kariri, M Althobiti, S Alsaeed, ... s Note: MDPI stays neu-tral with regard to jurisdictional clai-ms in …, 2020 | | 2020 |
| The Prognostic Significance of PDZ Domain-containing 1 (PDZK1) in Invasive Breast Cancer and its Association with ER Heterogeneity FQ Goh, C Joseph, MS Toss, M Althobiti, M Arshad, S Al-izzi, S Kurozumi, ... JOURNAL OF PATHOLOGY 249, S25-S25, 2019 | | 2019 |
| The Prognostic Significant of the Stem Cell Marker ALDH1A1 in Breast Cancer M Althobiti, R El Ansari, C Joseph, I Ellis, A Green, E Rakha JOURNAL OF PATHOLOGY 249, S26-S26, 2019 | | 2019 |
| CD133 Over-Expression in Breast Cancer: A Marker of Poor Prognosis C Joseph, M Arshad, S Kurozumi, M Althobiti, IM Miligy, S Al-izzi, MS Toss, ... JOURNAL OF PATHOLOGY 249, S24-S24, 2019 | | 2019 |
| A Hybrid Pipeline to Assess Oestrogen Receptor Stained Nuclei in Invasive Breast Cancer HM AlGhamdi, M Althobiti, T Qaiser, AR Green, SEA Raza, EA Rakha, ... MICCAI 2019 Computational Pathology Workshop COMPAY, 2019 | | 2019 |
| The Heterogeneity of Tumour Infiltrating Lymphocytes and its Effect on Patient Outcome M Althobiti, MA Aleskandarany, AR Green, C Joseph, MD Rodriguez, ... JOURNAL OF PATHOLOGY 243, S17-S17, 2017 | | 2017 |
| Zinc Finger Protein 22: a Potential Metastatic Progression Biomarker in Invasive Breast Cancer M Althobiti, MA Aleskandarany, AR Green, MD Rodriguez, CC Nolan, ... JOURNAL OF PATHOLOGY 241, S9-S9, 2017 | | 2017 |
